Global (United States, European Union and China) Pediatric Drugs

Pediatric Drugs Comprehensive Study by Type (Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drugs, Urological Drugs), Application (Hospital, Clinic, Drugstore), Form (Tablets, Powder, Injection, Others) Players and Region - Global Market Outlook to 2027

Pediatric Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pediatric Drugs?
Growing prevalence of pediatric diseases will help to boost global pediatric drug market in the forecasted period. Pediatric drugs are a special class of drugs which are prescribed to children and infants for various diseases. These drugs are applicable in various conditions such as asthma, birth defects, anorexia, cancer in children, growth deficiencies, juvenile diabetes, attention deficit hyperactivity disorder, and many others.

AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketAsia Pacific
Largest MarketNorth America
UnitValue (USD Million)
Key Companies ProfiledAbbott Laboratories (United States), Bayer (Germany), Eli Lilly (United States), Forest Laboratories (United States), GlaxoSmithKline (United Kingdom), Johnson & Johnson (United States), Novartis Pharmaceuticals (Switzerland), Novo Nordisk (Denmark), Merck (United States) and Pfizer (United States)


The study covers a detailed analysis segmented by key business segments i.e. by type (Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drugs and Urological Drugs) , by application (Hospital, Clinic and Drugstore) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pediatric Drugs market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Pediatric Drugs market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Abbott Laboratories (United States), Bayer (Germany), Eli Lilly (United States), Forest Laboratories (United States), GlaxoSmithKline (United Kingdom), Johnson & Johnson (United States), Novartis Pharmaceuticals (Switzerland), Novo Nordisk (Denmark), Merck (United States) and Pfizer (United States).

Market Overview:
On 2nd January 2019, Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.
The Best Pharmaceuticals for Children Act (BPCA) became law in 2002. It was reauthorized in 2007 under the Food and Drug Administration (FDA) Amendments Act, in 2012 under the FDA Safety and Innovation Act, and again in 2017 under the FDA Reauthorization Act. According to the act, “To encourage the pharmaceutical industry to perform pediatric studies to improve labeling for patented drug products used in children, by granting an additional 6 months patent exclusivity. For NIH to prioritize therapeutic areas and sponsor clinical trials and other research for off-patent drug products that need further study in children”

Pediatric Drugs Market Dynamics:
AttributesDetails
Growth Drivers
  • Rising Government Support and Initiation of National Programs
  • Fueling Demand for Chronic Treatment Drugs
Major Trends
  • Increasing investment on R & D for Pediatric Drug
  • Growing Incidences of Obesity
Restraints
  • Low Disposable Income
  • Concerns Regarding Adverse Side Effects
Road Blocks / Challenges
  • Lack of Awareness in Developing Countries
Gaps & Opportunities
  • Technological Advancement in the Pediatric Field


Key highlights of the Global Pediatric Drugs market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Pediatric Drugs market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global Pediatric Drugs market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Pediatric Drugs Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pediatric Drugs market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Pediatric Drugs market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Pediatric Drug Manufactures, Suppliers and Distributors, Pharmaceuticals Companies, Industry Associations, Government Regulatory Bodies, Government and Private Research Organizations and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Allergy and Respiratory Drugs
  • Anti-Infectives
  • Cancer Therapies
  • Cardiovascular Drugs
  • Central Nervous System Drugs
  • Gastrointestinal Drugs
  • Hormone Drugs
  • Urological Drugs
By Application
  • Hospital
  • Clinic
  • Drugstore
By Form
  • Tablets
  • Powder
  • Injection
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Government Support and Initiation of National Programs
      • 3.2.2. Fueling Demand for Chronic Treatment Drugs
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Increasing investment on R & D for Pediatric Drug
      • 3.4.2. Growing Incidences of Obesity
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pediatric Drugs, by Type, Application, Form and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pediatric Drugs (Value)
      • 5.2.1. Global Pediatric Drugs by: Type (Value)
        • 5.2.1.1. Allergy and Respiratory Drugs
        • 5.2.1.2. Anti-Infectives
        • 5.2.1.3. Cancer Therapies
        • 5.2.1.4. Cardiovascular Drugs
        • 5.2.1.5. Central Nervous System Drugs
        • 5.2.1.6. Gastrointestinal Drugs
        • 5.2.1.7. Hormone Drugs
        • 5.2.1.8. Urological Drugs
      • 5.2.2. Global Pediatric Drugs by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Drugstore
      • 5.2.3. Global Pediatric Drugs by: Form (Value)
        • 5.2.3.1. Tablets
        • 5.2.3.2. Powder
        • 5.2.3.3. Injection
        • 5.2.3.4. Others
      • 5.2.4. Global Pediatric Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pediatric Drugs (Volume)
      • 5.3.1. Global Pediatric Drugs by: Type (Volume)
        • 5.3.1.1. Allergy and Respiratory Drugs
        • 5.3.1.2. Anti-Infectives
        • 5.3.1.3. Cancer Therapies
        • 5.3.1.4. Cardiovascular Drugs
        • 5.3.1.5. Central Nervous System Drugs
        • 5.3.1.6. Gastrointestinal Drugs
        • 5.3.1.7. Hormone Drugs
        • 5.3.1.8. Urological Drugs
      • 5.3.2. Global Pediatric Drugs by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. Drugstore
      • 5.3.3. Global Pediatric Drugs by: Form (Volume)
        • 5.3.3.1. Tablets
        • 5.3.3.2. Powder
        • 5.3.3.3. Injection
        • 5.3.3.4. Others
      • 5.3.4. Global Pediatric Drugs Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Pediatric Drugs (Price)
      • 5.4.1. Global Pediatric Drugs by: Type (Price)
  • 6. Pediatric Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eli Lilly (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Forest Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GlaxoSmithKline (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson & Johnson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis Pharmaceuticals (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novo Nordisk (Denmark)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pfizer (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pediatric Drugs Sale, by Type, Application, Form and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pediatric Drugs (Value)
      • 7.2.1. Global Pediatric Drugs by: Type (Value)
        • 7.2.1.1. Allergy and Respiratory Drugs
        • 7.2.1.2. Anti-Infectives
        • 7.2.1.3. Cancer Therapies
        • 7.2.1.4. Cardiovascular Drugs
        • 7.2.1.5. Central Nervous System Drugs
        • 7.2.1.6. Gastrointestinal Drugs
        • 7.2.1.7. Hormone Drugs
        • 7.2.1.8. Urological Drugs
      • 7.2.2. Global Pediatric Drugs by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Drugstore
      • 7.2.3. Global Pediatric Drugs by: Form (Value)
        • 7.2.3.1. Tablets
        • 7.2.3.2. Powder
        • 7.2.3.3. Injection
        • 7.2.3.4. Others
      • 7.2.4. Global Pediatric Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pediatric Drugs (Volume)
      • 7.3.1. Global Pediatric Drugs by: Type (Volume)
        • 7.3.1.1. Allergy and Respiratory Drugs
        • 7.3.1.2. Anti-Infectives
        • 7.3.1.3. Cancer Therapies
        • 7.3.1.4. Cardiovascular Drugs
        • 7.3.1.5. Central Nervous System Drugs
        • 7.3.1.6. Gastrointestinal Drugs
        • 7.3.1.7. Hormone Drugs
        • 7.3.1.8. Urological Drugs
      • 7.3.2. Global Pediatric Drugs by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. Drugstore
      • 7.3.3. Global Pediatric Drugs by: Form (Volume)
        • 7.3.3.1. Tablets
        • 7.3.3.2. Powder
        • 7.3.3.3. Injection
        • 7.3.3.4. Others
      • 7.3.4. Global Pediatric Drugs Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Pediatric Drugs (Price)
      • 7.4.1. Global Pediatric Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pediatric Drugs: by Type(USD Million)
  • Table 2. Pediatric Drugs Allergy and Respiratory Drugs , by Region USD Million (2016-2021)
  • Table 3. Pediatric Drugs Anti-Infectives , by Region USD Million (2016-2021)
  • Table 4. Pediatric Drugs Cancer Therapies , by Region USD Million (2016-2021)
  • Table 5. Pediatric Drugs Cardiovascular Drugs , by Region USD Million (2016-2021)
  • Table 6. Pediatric Drugs Central Nervous System Drugs , by Region USD Million (2016-2021)
  • Table 7. Pediatric Drugs Gastrointestinal Drugs , by Region USD Million (2016-2021)
  • Table 8. Pediatric Drugs Hormone Drugs , by Region USD Million (2016-2021)
  • Table 9. Pediatric Drugs Urological Drugs , by Region USD Million (2016-2021)
  • Table 10. Pediatric Drugs: by Application(USD Million)
  • Table 11. Pediatric Drugs Hospital , by Region USD Million (2016-2021)
  • Table 12. Pediatric Drugs Clinic , by Region USD Million (2016-2021)
  • Table 13. Pediatric Drugs Drugstore , by Region USD Million (2016-2021)
  • Table 14. Pediatric Drugs: by Form(USD Million)
  • Table 15. Pediatric Drugs Tablets , by Region USD Million (2016-2021)
  • Table 16. Pediatric Drugs Powder , by Region USD Million (2016-2021)
  • Table 17. Pediatric Drugs Injection , by Region USD Million (2016-2021)
  • Table 18. Pediatric Drugs Others , by Region USD Million (2016-2021)
  • Table 19. South America Pediatric Drugs, by Country USD Million (2016-2021)
  • Table 20. South America Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 21. South America Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 22. South America Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 23. Brazil Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 24. Brazil Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 25. Brazil Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 26. Argentina Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 27. Argentina Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 28. Argentina Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 29. Rest of South America Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 30. Rest of South America Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 31. Rest of South America Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 32. Asia Pacific Pediatric Drugs, by Country USD Million (2016-2021)
  • Table 33. Asia Pacific Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 34. Asia Pacific Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 35. Asia Pacific Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 36. China Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 37. China Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 38. China Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 39. Japan Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 40. Japan Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 41. Japan Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 42. India Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 43. India Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 44. India Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 45. South Korea Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 46. South Korea Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 47. South Korea Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 48. Taiwan Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 49. Taiwan Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 50. Taiwan Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 51. Australia Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 52. Australia Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 53. Australia Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 57. Europe Pediatric Drugs, by Country USD Million (2016-2021)
  • Table 58. Europe Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 59. Europe Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 60. Europe Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 61. Germany Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 62. Germany Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 63. Germany Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 64. France Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 65. France Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 66. France Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 67. Italy Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 68. Italy Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 69. Italy Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 70. United Kingdom Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 71. United Kingdom Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 72. United Kingdom Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 73. Netherlands Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 74. Netherlands Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 75. Netherlands Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 76. Rest of Europe Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 77. Rest of Europe Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 78. Rest of Europe Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 79. MEA Pediatric Drugs, by Country USD Million (2016-2021)
  • Table 80. MEA Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 81. MEA Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 82. MEA Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 83. Middle East Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 84. Middle East Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 85. Middle East Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 86. Africa Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 87. Africa Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 88. Africa Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 89. North America Pediatric Drugs, by Country USD Million (2016-2021)
  • Table 90. North America Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 91. North America Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 92. North America Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 93. United States Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 94. United States Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 95. United States Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 96. Canada Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 97. Canada Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 98. Canada Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 99. Mexico Pediatric Drugs, by Type USD Million (2016-2021)
  • Table 100. Mexico Pediatric Drugs, by Application USD Million (2016-2021)
  • Table 101. Mexico Pediatric Drugs, by Form USD Million (2016-2021)
  • Table 102. Pediatric Drugs Sales: by Type(K Unit)
  • Table 103. Pediatric Drugs Sales Allergy and Respiratory Drugs , by Region K Unit (2016-2021)
  • Table 104. Pediatric Drugs Sales Anti-Infectives , by Region K Unit (2016-2021)
  • Table 105. Pediatric Drugs Sales Cancer Therapies , by Region K Unit (2016-2021)
  • Table 106. Pediatric Drugs Sales Cardiovascular Drugs , by Region K Unit (2016-2021)
  • Table 107. Pediatric Drugs Sales Central Nervous System Drugs , by Region K Unit (2016-2021)
  • Table 108. Pediatric Drugs Sales Gastrointestinal Drugs , by Region K Unit (2016-2021)
  • Table 109. Pediatric Drugs Sales Hormone Drugs , by Region K Unit (2016-2021)
  • Table 110. Pediatric Drugs Sales Urological Drugs , by Region K Unit (2016-2021)
  • Table 111. Pediatric Drugs Sales: by Application(K Unit)
  • Table 112. Pediatric Drugs Sales Hospital , by Region K Unit (2016-2021)
  • Table 113. Pediatric Drugs Sales Clinic , by Region K Unit (2016-2021)
  • Table 114. Pediatric Drugs Sales Drugstore , by Region K Unit (2016-2021)
  • Table 115. Pediatric Drugs Sales: by Form(K Unit)
  • Table 116. Pediatric Drugs Sales Tablets , by Region K Unit (2016-2021)
  • Table 117. Pediatric Drugs Sales Powder , by Region K Unit (2016-2021)
  • Table 118. Pediatric Drugs Sales Injection , by Region K Unit (2016-2021)
  • Table 119. Pediatric Drugs Sales Others , by Region K Unit (2016-2021)
  • Table 120. South America Pediatric Drugs Sales, by Country K Unit (2016-2021)
  • Table 121. South America Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 122. South America Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 123. South America Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 124. Brazil Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 125. Brazil Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 126. Brazil Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 127. Argentina Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 128. Argentina Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 129. Argentina Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 130. Rest of South America Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 131. Rest of South America Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 132. Rest of South America Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 133. Asia Pacific Pediatric Drugs Sales, by Country K Unit (2016-2021)
  • Table 134. Asia Pacific Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 135. Asia Pacific Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 136. Asia Pacific Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 137. China Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 138. China Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 139. China Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 140. Japan Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 141. Japan Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 142. Japan Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 143. India Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 144. India Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 145. India Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 146. South Korea Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 147. South Korea Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 148. South Korea Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 149. Taiwan Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 150. Taiwan Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 151. Taiwan Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 152. Australia Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 153. Australia Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 154. Australia Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 155. Rest of Asia-Pacific Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 156. Rest of Asia-Pacific Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 157. Rest of Asia-Pacific Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 158. Europe Pediatric Drugs Sales, by Country K Unit (2016-2021)
  • Table 159. Europe Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 160. Europe Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 161. Europe Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 162. Germany Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 163. Germany Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 164. Germany Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 165. France Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 166. France Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 167. France Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 168. Italy Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 169. Italy Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 170. Italy Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 171. United Kingdom Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 172. United Kingdom Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 173. United Kingdom Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 174. Netherlands Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 175. Netherlands Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 176. Netherlands Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 177. Rest of Europe Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 178. Rest of Europe Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 179. Rest of Europe Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 180. MEA Pediatric Drugs Sales, by Country K Unit (2016-2021)
  • Table 181. MEA Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 182. MEA Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 183. MEA Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 184. Middle East Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 185. Middle East Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 186. Middle East Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 187. Africa Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 188. Africa Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 189. Africa Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 190. North America Pediatric Drugs Sales, by Country K Unit (2016-2021)
  • Table 191. North America Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 192. North America Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 193. North America Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 194. United States Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 195. United States Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 196. United States Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 197. Canada Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 198. Canada Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 199. Canada Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 200. Mexico Pediatric Drugs Sales, by Type K Unit (2016-2021)
  • Table 201. Mexico Pediatric Drugs Sales, by Application K Unit (2016-2021)
  • Table 202. Mexico Pediatric Drugs Sales, by Form K Unit (2016-2021)
  • Table 203. Pediatric Drugs: by Type(USD/Units)
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Pediatric Drugs: by Type(USD Million)
  • Table 215. Pediatric Drugs Allergy and Respiratory Drugs , by Region USD Million (2022-2027)
  • Table 216. Pediatric Drugs Anti-Infectives , by Region USD Million (2022-2027)
  • Table 217. Pediatric Drugs Cancer Therapies , by Region USD Million (2022-2027)
  • Table 218. Pediatric Drugs Cardiovascular Drugs , by Region USD Million (2022-2027)
  • Table 219. Pediatric Drugs Central Nervous System Drugs , by Region USD Million (2022-2027)
  • Table 220. Pediatric Drugs Gastrointestinal Drugs , by Region USD Million (2022-2027)
  • Table 221. Pediatric Drugs Hormone Drugs , by Region USD Million (2022-2027)
  • Table 222. Pediatric Drugs Urological Drugs , by Region USD Million (2022-2027)
  • Table 223. Pediatric Drugs: by Application(USD Million)
  • Table 224. Pediatric Drugs Hospital , by Region USD Million (2022-2027)
  • Table 225. Pediatric Drugs Clinic , by Region USD Million (2022-2027)
  • Table 226. Pediatric Drugs Drugstore , by Region USD Million (2022-2027)
  • Table 227. Pediatric Drugs: by Form(USD Million)
  • Table 228. Pediatric Drugs Tablets , by Region USD Million (2022-2027)
  • Table 229. Pediatric Drugs Powder , by Region USD Million (2022-2027)
  • Table 230. Pediatric Drugs Injection , by Region USD Million (2022-2027)
  • Table 231. Pediatric Drugs Others , by Region USD Million (2022-2027)
  • Table 232. South America Pediatric Drugs, by Country USD Million (2022-2027)
  • Table 233. South America Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 234. South America Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 235. South America Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 236. Brazil Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 237. Brazil Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 238. Brazil Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 239. Argentina Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 240. Argentina Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 241. Argentina Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 242. Rest of South America Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 243. Rest of South America Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 244. Rest of South America Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 245. Asia Pacific Pediatric Drugs, by Country USD Million (2022-2027)
  • Table 246. Asia Pacific Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 247. Asia Pacific Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 248. Asia Pacific Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 249. China Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 250. China Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 251. China Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 252. Japan Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 253. Japan Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 254. Japan Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 255. India Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 256. India Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 257. India Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 258. South Korea Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 259. South Korea Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 260. South Korea Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 261. Taiwan Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 262. Taiwan Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 263. Taiwan Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 264. Australia Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 265. Australia Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 266. Australia Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 267. Rest of Asia-Pacific Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 268. Rest of Asia-Pacific Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 269. Rest of Asia-Pacific Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 270. Europe Pediatric Drugs, by Country USD Million (2022-2027)
  • Table 271. Europe Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 272. Europe Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 273. Europe Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 274. Germany Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 275. Germany Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 276. Germany Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 277. France Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 278. France Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 279. France Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 280. Italy Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 281. Italy Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 282. Italy Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 283. United Kingdom Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 284. United Kingdom Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 285. United Kingdom Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 286. Netherlands Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 287. Netherlands Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 288. Netherlands Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 289. Rest of Europe Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 290. Rest of Europe Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 291. Rest of Europe Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 292. MEA Pediatric Drugs, by Country USD Million (2022-2027)
  • Table 293. MEA Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 294. MEA Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 295. MEA Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 296. Middle East Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 297. Middle East Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 298. Middle East Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 299. Africa Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 300. Africa Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 301. Africa Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 302. North America Pediatric Drugs, by Country USD Million (2022-2027)
  • Table 303. North America Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 304. North America Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 305. North America Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 306. United States Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 307. United States Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 308. United States Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 309. Canada Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 310. Canada Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 311. Canada Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 312. Mexico Pediatric Drugs, by Type USD Million (2022-2027)
  • Table 313. Mexico Pediatric Drugs, by Application USD Million (2022-2027)
  • Table 314. Mexico Pediatric Drugs, by Form USD Million (2022-2027)
  • Table 315. Pediatric Drugs Sales: by Type(K Unit)
  • Table 316. Pediatric Drugs Sales Allergy and Respiratory Drugs , by Region K Unit (2022-2027)
  • Table 317. Pediatric Drugs Sales Anti-Infectives , by Region K Unit (2022-2027)
  • Table 318. Pediatric Drugs Sales Cancer Therapies , by Region K Unit (2022-2027)
  • Table 319. Pediatric Drugs Sales Cardiovascular Drugs , by Region K Unit (2022-2027)
  • Table 320. Pediatric Drugs Sales Central Nervous System Drugs , by Region K Unit (2022-2027)
  • Table 321. Pediatric Drugs Sales Gastrointestinal Drugs , by Region K Unit (2022-2027)
  • Table 322. Pediatric Drugs Sales Hormone Drugs , by Region K Unit (2022-2027)
  • Table 323. Pediatric Drugs Sales Urological Drugs , by Region K Unit (2022-2027)
  • Table 324. Pediatric Drugs Sales: by Application(K Unit)
  • Table 325. Pediatric Drugs Sales Hospital , by Region K Unit (2022-2027)
  • Table 326. Pediatric Drugs Sales Clinic , by Region K Unit (2022-2027)
  • Table 327. Pediatric Drugs Sales Drugstore , by Region K Unit (2022-2027)
  • Table 328. Pediatric Drugs Sales: by Form(K Unit)
  • Table 329. Pediatric Drugs Sales Tablets , by Region K Unit (2022-2027)
  • Table 330. Pediatric Drugs Sales Powder , by Region K Unit (2022-2027)
  • Table 331. Pediatric Drugs Sales Injection , by Region K Unit (2022-2027)
  • Table 332. Pediatric Drugs Sales Others , by Region K Unit (2022-2027)
  • Table 333. South America Pediatric Drugs Sales, by Country K Unit (2022-2027)
  • Table 334. South America Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 335. South America Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 336. South America Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 337. Brazil Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 338. Brazil Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 339. Brazil Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 340. Argentina Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 341. Argentina Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 342. Argentina Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 343. Rest of South America Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 344. Rest of South America Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 345. Rest of South America Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 346. Asia Pacific Pediatric Drugs Sales, by Country K Unit (2022-2027)
  • Table 347. Asia Pacific Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 348. Asia Pacific Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 349. Asia Pacific Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 350. China Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 351. China Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 352. China Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 353. Japan Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 354. Japan Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 355. Japan Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 356. India Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 357. India Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 358. India Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 359. South Korea Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 360. South Korea Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 361. South Korea Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 362. Taiwan Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 363. Taiwan Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 364. Taiwan Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 365. Australia Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 366. Australia Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 367. Australia Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 368. Rest of Asia-Pacific Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 369. Rest of Asia-Pacific Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 370. Rest of Asia-Pacific Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 371. Europe Pediatric Drugs Sales, by Country K Unit (2022-2027)
  • Table 372. Europe Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 373. Europe Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 374. Europe Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 375. Germany Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 376. Germany Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 377. Germany Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 378. France Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 379. France Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 380. France Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 381. Italy Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 382. Italy Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 383. Italy Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 384. United Kingdom Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 385. United Kingdom Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 386. United Kingdom Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 387. Netherlands Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 388. Netherlands Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 389. Netherlands Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 390. Rest of Europe Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 391. Rest of Europe Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 392. Rest of Europe Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 393. MEA Pediatric Drugs Sales, by Country K Unit (2022-2027)
  • Table 394. MEA Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 395. MEA Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 396. MEA Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 397. Middle East Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 398. Middle East Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 399. Middle East Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 400. Africa Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 401. Africa Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 402. Africa Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 403. North America Pediatric Drugs Sales, by Country K Unit (2022-2027)
  • Table 404. North America Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 405. North America Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 406. North America Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 407. United States Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 408. United States Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 409. United States Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 410. Canada Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 411. Canada Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 412. Canada Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 413. Mexico Pediatric Drugs Sales, by Type K Unit (2022-2027)
  • Table 414. Mexico Pediatric Drugs Sales, by Application K Unit (2022-2027)
  • Table 415. Mexico Pediatric Drugs Sales, by Form K Unit (2022-2027)
  • Table 416. Pediatric Drugs: by Type(USD/Units)
  • Table 417. Research Programs/Design for This Report
  • Table 418. Key Data Information from Secondary Sources
  • Table 419. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pediatric Drugs: by Type USD Million (2016-2021)
  • Figure 5. Global Pediatric Drugs: by Application USD Million (2016-2021)
  • Figure 6. Global Pediatric Drugs: by Form USD Million (2016-2021)
  • Figure 7. South America Pediatric Drugs Share (%), by Country
  • Figure 8. Asia Pacific Pediatric Drugs Share (%), by Country
  • Figure 9. Europe Pediatric Drugs Share (%), by Country
  • Figure 10. MEA Pediatric Drugs Share (%), by Country
  • Figure 11. North America Pediatric Drugs Share (%), by Country
  • Figure 12. Global Pediatric Drugs: by Type K Unit (2016-2021)
  • Figure 13. Global Pediatric Drugs: by Application K Unit (2016-2021)
  • Figure 14. Global Pediatric Drugs: by Form K Unit (2016-2021)
  • Figure 15. South America Pediatric Drugs Share (%), by Country
  • Figure 16. Asia Pacific Pediatric Drugs Share (%), by Country
  • Figure 17. Europe Pediatric Drugs Share (%), by Country
  • Figure 18. MEA Pediatric Drugs Share (%), by Country
  • Figure 19. North America Pediatric Drugs Share (%), by Country
  • Figure 20. Global Pediatric Drugs: by Type USD/Units (2016-2021)
  • Figure 21. Global Pediatric Drugs share by Players 2021 (%)
  • Figure 22. Global Pediatric Drugs share by Players (Top 3) 2021(%)
  • Figure 23. Global Pediatric Drugs share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 27. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Bayer (Germany) Revenue: by Geography 2021
  • Figure 29. Eli Lilly (United States) Revenue, Net Income and Gross profit
  • Figure 30. Eli Lilly (United States) Revenue: by Geography 2021
  • Figure 31. Forest Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. Forest Laboratories (United States) Revenue: by Geography 2021
  • Figure 33. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2021
  • Figure 35. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 36. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 37. Novartis Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Novartis Pharmaceuticals (Switzerland) Revenue: by Geography 2021
  • Figure 39. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 40. Novo Nordisk (Denmark) Revenue: by Geography 2021
  • Figure 41. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 42. Merck (United States) Revenue: by Geography 2021
  • Figure 43. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 44. Pfizer (United States) Revenue: by Geography 2021
  • Figure 45. Global Pediatric Drugs: by Type USD Million (2022-2027)
  • Figure 46. Global Pediatric Drugs: by Application USD Million (2022-2027)
  • Figure 47. Global Pediatric Drugs: by Form USD Million (2022-2027)
  • Figure 48. South America Pediatric Drugs Share (%), by Country
  • Figure 49. Asia Pacific Pediatric Drugs Share (%), by Country
  • Figure 50. Europe Pediatric Drugs Share (%), by Country
  • Figure 51. MEA Pediatric Drugs Share (%), by Country
  • Figure 52. North America Pediatric Drugs Share (%), by Country
  • Figure 53. Global Pediatric Drugs: by Type K Unit (2022-2027)
  • Figure 54. Global Pediatric Drugs: by Application K Unit (2022-2027)
  • Figure 55. Global Pediatric Drugs: by Form K Unit (2022-2027)
  • Figure 56. South America Pediatric Drugs Share (%), by Country
  • Figure 57. Asia Pacific Pediatric Drugs Share (%), by Country
  • Figure 58. Europe Pediatric Drugs Share (%), by Country
  • Figure 59. MEA Pediatric Drugs Share (%), by Country
  • Figure 60. North America Pediatric Drugs Share (%), by Country
  • Figure 61. Global Pediatric Drugs: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Bayer (Germany)
  • Eli Lilly (United States)
  • Forest Laboratories (United States)
  • GlaxoSmithKline (United Kingdom)
  • Johnson & Johnson (United States)
  • Novartis Pharmaceuticals (Switzerland)
  • Novo Nordisk (Denmark)
  • Merck (United States)
  • Pfizer (United States)
Additional players considered in the study are as follows:
Boehringer Ingelheim (Germany) , MedImmune (United States) , Genentech (United States) , Colgate Oral Pharmaceuticals (United States) , Bristol-Myers Squibb (United States) , Pharmacia (United States) , Roche (Switzerland) , Schering-Plough (United States)
Select User Access Type

Key Highlights of Report


Aug 2022 170 Pages 75 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Pediatric Drugs Quantitative research analysis
Global (United States, European Union and China) Pediatric Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Pediatric Drugs Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global Pediatric Drugs market is dominated by United States Players and may generate healthy valuation by 2027.
  • Rising Government Support and Initiation of National Programs
  • Fueling Demand for Chronic Treatment Drugs
dominated the Pediatric Drugs market. This is attributable to growing trend of "Increasing investment on R & D for Pediatric Drug "

Know More About Global (United States, European Union and China) Pediatric Drugs Report?

Have a Query? Click Here

Other Related Reports

Soft Gelatin Capsules Comprehensive Study by Type (Gelatin, Non-Animal), Application (Pharmaceutical, Health Supplements, Others), Distribution Channel (Online, Offline), Outer Shell (Gelatin, Plasti...
$ 3350
Oral Thin Films Comprehensive Study by Type (Oromucosal, Orodispersible, • Orally Disintegrating, • Orally Dissolving), Application (Allergy/Cough and Cold, Pain Management, Anti-flatulence, Neurolog...
$ 3650
Animal Nutrition Comprehensive Study by Type (Minerals, Amino Acids, Vitamins, Enzymes, Others), Application (Poultry Feeds, Ruminant Feeds, Pig Feeds, Aquaculture Feeds, Others), Form (Dry, Liquid) ...
$ 3500
Compounding Pharmacies Comprehensive Study by Type (Oral Medication (Capsules, Tablets, Suspensions, Lozenges, and Others), Topical Medication (Creams, Gels, Ointments, and Others), Mouthwashes, Supp...
$ 3750
Vitamin B3 Comprehensive Study by Type (Pharmaceutical Grade, Feed Grade), Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals) Players and Region - Global...
$ 3500
Pharmaceutical & Biotechnology Environmental Monitoring Comprehensive Study by Type (Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Sy...
$ 3350